Metabolic & Cardiometabolic

Part of Biotech - Drug Development
LLYLLYEli Lilly & Co.$1.3t$1442.76-0.2%1.5M
AZNAZNAstraZeneca PLC$285.2b$184.85+0.1%999.2K
MDGLMDGLMadrigal Pharmaceuticals, Inc. Common Stock$9.2b$423.67-1.0%195.8K
PTGXPTGXProtagonist Therapeutics, Inc$9.1b$125.03-4.0%170.8K
KNSAKNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares$7.3b$95.16-1.2%166.2K
TERNTERNTerns Pharmaceuticals, Inc. Common Stock$6.1b$52.97+0.0%2.3M
TVTXTVTXTravere Therapeutics, Inc. Common Stock$4.7b$49.84-1.5%386.6K
VKTXVKTXViking Therapeutics, Inc$3.3b$26.83-8.2%1.8M
MBXMBXMBX Biosciences, Inc. Common Stock$2.6b$53.49-4.3%121.2K
NAMSNAMSNewAmsterdam Pharma Company N.V. Ordinary Shares$2.4b$19.80-1.2%490.8K
SEPNSEPNSepterna, Inc. Common Stock$2.0b$41.55-2.4%177.3K
MAZEMAZEMaze Therapeutics, Inc. Common Stock$1.8b$34.26-0.3%268.7K
KLRAKLRAKailera Therapeutics, Inc. Common Stock$1.7b$12.65-4.4%637.5K
MLYSMLYSMineralys Therapeutics, Inc. Common Stock$1.4b$14.78-3.5%324.1K
MNKDMNKDMannkind Corporation$1.2b$3.92-4.2%1.3M
KARDKARDKardigan, Inc. Common Stock$1.2b$12.77-7.5%181.9K
ESPRESPREsperion Therapeutics, Inc.$0.8b$3.190.0%N/A
SGMTSGMTSagimet Biosciences Inc. Series A Common Stock$0.7b$10.20-0.0%307.8K
LXRXLXRXLexicon Pharmaceuticals, Inc.$0.6b$1.75-2.8%523.2K
GYREGYREGyre Therapeutics, Inc. Common Stock$470.8m$4.63+7.9%280.6K
ALTALTAltimmune, Inc. Common Stock$396.8m$1.57-3.6%3.8M
RZLTRZLTRezolute, Inc. Common Stock (NV)$387.9m$3.52-4.0%3.0M
BIOABIOABioAge Labs, Inc. Common Stock$273.5m$5.11-7.2%272.4K
ORMPORMPOramed Pharmaceuticals Inc.$166.4m$3.90+5.7%251.5K
CRDLCRDLCardiol Therapeutics Inc. Class A Common Shares$127.6m$0.96-2.6%159.2K
VANIVANIVivani Medical, Inc. Common Stock (DE)$94.7m$1.02+1.5%365.6K
MISTMISTMilestone Pharmaceuticals Inc. Common Shares$94.5m$0.43-14.9%4.4M
VTVTVTVTvTv Therapeutics Inc. Class A Common Stock$93.1m$17.48-8.8%12.3K
TENXTENXTenax Therapeutics, Inc.$68.9m$1.48-8.6%502.4K
BMEABMEABiomea Fusion, Inc. Common Stock$45.2m$0.53-10.7%378.2K
GRDXGRDXGridAI Technologies Corp. Common Stock$42.9m$3.33-2.4%278.4K
VERUVERUVeru Inc.$36.8m$2.11-1.7%66.5K
ALGSALGSAligos Therapeutics, Inc. Common Stock$29.7m$1.71-17.1%96.2K
AARDAARDAardvark Therapeutics, Inc. Common Stock$26.9m$1.26-3.0%147.3K
NCELNCELNewcelX Ltd. Ordinary Shares$15.2m$2.73+2.9%5.4K
LPCNLPCNLipocine Inc.$12.0m$1.64-2.3%87.3K
GUTSGUTSFractyl Health, Inc. Common Stock$11.9m$1.02+12.9%570.5K
CURXCURXCuranex Pharmaceuticals Inc Common Stock$9.7m$4.660.0%3.5K
MTVAMTVAMetaVia Inc. Common Stock$8.3m$1.27-3.1%39.3K
SKYESKYESkye Bioscience, Inc. Common Stock$5.4m$1.16+0.9%44.0K
TCRTTCRTAlaunos Therapeutics, Inc. Common Stock$4.7m$1.60-1.8%52.3K
GLMDGLMDGalmed Pharmaceuticals Ltd.$4.3m$4.590.0%N/A
CVKDCVKDCadrenal Therapeutics, Inc. Common Stock$4.0m$1.48-3.0%60.9K
ELABELABPMGC Holdings Inc. Common Stock$1.6m$1.77+7.6%1.3M

Explore Similar Themes